Now, this is what we’ve all been looking for. A bull that grabbed the bear by its tail and threw it down a couple flight of stairs. Bing! Boom! Bang! Ouch!
Go away bear, we are going up!
$DMRC formed a solid green bullish engulfment bar for the day.
Price closed above the 79 & 89 MA supports. Momentum indicators are turning up from below. There is a high probability of an upward momentum.
$IBIO, $BIOC, $RBY, and $AKAO are all locked in the trading range for now. These are incubators waiting for their time to shine next year.
Meanwhile, $ARTH got news: Arch Therapeutics Receives Clearance to Initiate Clinical Trial in Europe. Surprisingly, price did not spike as high as everyone thought it would. But then, we still have to wait for the result. At least, we got one hurdle out of the way. Since AC5 is a medical device and does not create any biological or chemical interaction with the human organs except to form a scaffold over the bleeding wound to stop the bleeding, I expect the trial to pass the test in flying color since it has already been proven to work on animal organs. Metaphorically speaking, if you can put a clamp on an animal blood vessel and it stops the bleeding, you can pretty much assume that putting the same clamp on a human blood vessel, it will stop the bleeding as well.
Perhaps there is a delayed effect from the news and price will start to climb pretty fast from here. This is now a much easier wait from here.
Stilling holding all my shares on $DMRC, $IBIO, $BIOC, $RBY, $AKAO, $ARTH.
My 2 cents